Skip to main content

Closed

SANA: Sana Biotechnology, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-78.6%

Financially safe

Stretched

Debt / equity0.63×

Interest coverage0.0×

Current ratio1.29×

Sana Biotechnology, Inc.

SANANASDAQ Global Select·USD·Closed

Sana Biotechnology, Inc.

SANANASDAQ·USD·Closed

$3.13

−3.69%

$3.13

−$0.12 (3.69%)

52W Range

13thpctl

Volume

0.63×avg

Mkt Cap

871.05MUSD

P/E

-3.4TTM

Div Yield

–ann

52W Range

13thpctl

Volume

0.63×avg

Market Cap

871.05MUSD

P/E Ratio

-3.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings